Nu Skin Enterprises (NUS) Stock Rose Fourfold in 2013

January 23, 2014

Direct beauty seller Nu Skin Enterprises’ (NUS) stock price rose fourfold in 2013 from previous year’s lows due to unfounded fears of being associated with Herbalife Ltd. (HLF), says Andrew Absler, a Senior Research Analyst at Lombardia Capital Partners, LLC, and Portfolio Manager for the Small Cap Value Portfolio.

“The fears proved unfounded, and the stock experienced both multiple expansion and tremendous earnings growth. Today the stock is in excess of $130, which is approximately a fourfold increase from its lows,” Absler explained.

FOR MORE INFORMATION ABOUT THIS INTERVIEW CLICK HERE.

Absler says about 10% of Nu Skin sales for its beauty and personal care products come from North America, and he says Asian markets currently provide significant growth for the direct seller.

Absler commented that Nu Skin’s stock performance in 2013 made it Small Cap Value Portfolio’s best performer. He added that others were not as keen on the stock during the controversy, but Lombardia did not follow the crowd. “Steve Malcolm is the primary analyst on the stock, and to his credit he stuck with the name during the controversy and pushed us to buy more when the stock was weak,” Absler said.